The CCDC6 gene helps cells respond to DNA damage and keep growth under control. This gene plays an important role in signals that tell damaged cells to pause, repair themselves, or stop dividing. If it does not work properly, damage may build up and cells may grow in a less controlled way, which can contribute to some cancers. Changes involving the CCDC6 gene are most often discussed in certain thyroid cancers and some lung cancers, where it can become fused to another gene.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes carry the information needed to produce proteins, the parts of cells that do the work. Other genes mainly control when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. If you want to go into this topic in more detail, you can find more in the LearnHub.
Overview
CCDC6Gene function
What if the gene works
The CCDC6 gene helps cells respond to damage in DNA and supports controlled cell growth. Its protein also helps regulate when certain genes are switched on or off.
Risk
What if the gene does not work
Changes in the CCDC6 gene can range from milder to more severe variants. When the CCDC6 gene works less well, cells may respond to DNA damage less effectively and regulate growth and cell death less precisely.
Treatment
What does that mean for your treatment
No CCDC6-specific treatment or management approach is currently established for pathogenic or loss-of-function variants in the CCDC6 gene. In cancer care, CCDC6 is mainly relevant as a fusion partner, such as CCDC6::RET, where treatment choices can include RET targeted drugs based on the RET fusion rather than CCDC6 loss itself.
Conditions associated with CCDC6
Gene function
What if the gene works
In everyday cell life, the CCDC6 gene helps manage DNA maintenance and orderly cell growth. It supports DNA repair and the built-in checkpoints that can pause cell division when needed. It also helps regulate how strongly some genes are turned on. Understanding the CCDC6 gene function helps explain how cells keep their genetic instructions stable over time.
The CCDC6 gene helps cells respond when DNA strands need repair. It works with repair proteins so breaks can be fixed in a more controlled way.
This gene supports checkpoints that let a cell pause before dividing. That pause gives the cell time to review its DNA and move forward in a more orderly way.
The CCDC6 gene also helps adjust the activity of selected genes inside the nucleus. By influencing these signals, it supports balanced cell growth and routine cell behavior.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene functions to a greater degree and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CCDC6 gene can change the protein’s shape, stability, or binding to partner proteins, which helps explain how CCDC6 gene variants affect cell repair after DNA damage. Milder variants may partly weaken these interactions, while more severe variants can truncate the protein or disrupt the gene’s normal control. In some cells, rearrangements that fuse CCDC6 to another gene can replace normal regulation with abnormal signaling.
How variants are linked to conditions
Research on how variants in the CCDC6 gene are linked to cancer is strongest for acquired gene rearrangements found in papillary thyroid cancer and, less often, in some lung cancers. These changes are usually detected in the tumor itself rather than inherited through a family. A CCDC6 finding on cancer testing can help classify the tumor, but it does not by itself mean relatives have the same risk.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant connected to a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, one specific well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CCDC6 gene itself. In some cancers, CCDC6 can become part of an acquired gene change in tumor cells, but this does not mean inherited CCDC6 changes have a clear, predictable risk pattern.
Inheritance of CCDC6 variants
There is not yet a broadly confirmed Mendelian pattern for how CCDC6 gene variants are inherited in relation to a specific inherited condition. In other words, CCDC6 gene inheritance is not currently described as a well-established autosomal dominant, autosomal recessive, or X-linked condition in routine medical genetics. The CCDC6 gene is located on chromosome 10, which is an autosome, so each person inherits one copy from each parent.
What does my CCDC6 result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific inherited condition for CCDC6. If you have a specific CCDC6 result and questions about what it could mean for your family, a doctor or genetic counselor can explain it in the context of your own test result and health history.
Genetic information
Genetic testing
How you find out about variants
CCDC6 genetic testing uses a blood, saliva, or tumor sample, depending on whether doctors are checking inherited DNA or changes in cancer cells. A lab reads the CCDC6 gene and may also look for gene fusions, then compares the result with a reference sequence to identify variants that can help clarify diagnosis or guide cancer care.
When should I consider getting a genetic test?
There is not yet a broadly established reason to have inherited genetic testing focused on the CCDC6 gene alone. In some thyroid or lung cancers, doctors may check the tumor for an abnormal joining of CCDC6 with another gene, because that can help guide diagnosis and treatment.
A genetic result is only one part of your health story
A genetic result can be informative, but what it can tell you varies with the condition and the kind of variant found. How your body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, particularly those affected by many genes, genetic information provides context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, kidney and liver function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how differences in genes affect the way people respond to medications. It examines connections between genes and drugs to clarify why the same treatment can work differently in different people. With many medicines, genes can influence how powerfully a drug works or how the body handles it. This information can support treatment decisions that are both more informed and more individualized. To explore this subject further, you can learn more in the LearnHub.
Drugs influenced by the CCDC6 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding everyday medication choices, so questions about side effects, treatment changes, or medicine safety are best discussed with your doctor. In cancer care, CCDC6 can sometimes join with another gene called RET in certain thyroid or lung cancers, and that tumor finding can shape conversations about targeted treatment.
History
The CCDC6 gene entered medical research through studies of papillary thyroid cancer in the 1990s. It was first identified under another name, H4, when researchers found that part of this gene could fuse with the RET gene in a common thyroid cancer rearrangement called RET/PTC1. From these first observations, research expanded steadily. The finding became especially important after thyroid cancers linked to radiation exposure, including cases studied after the Chernobyl accident, showed this fusion more often. As cancer genetics developed, H4 was renamed the CCDC6 gene, and its place in thyroid cancer research became clearer. This work helped shape how scientists classify and study gene rearrangements in solid tumors.